
pmid: 26233637
Copeptin, a C-terminal part of the precursor pre-provasopressin is a novel biomarker of arginine-vasopressin (AVP) system. Measurements of AVP concentration are not used in clinical practice because of technical difficulties. Copeptin is synthesized in stoichiometric ratio with AVP, hence it reflects vasopressin concentration in human plasma and serum. This review outlines current research concerning the role of copeptin as a prognostic marker in different diseases and its potential clinical value.
Heart Failure, chronic - metabolism, Glycopeptides, Arginine vasopressin - metabolism, Arginine Vasopressin, Heart failure - metabolism, Biomarkers - metabolism, Animals, Humans, Glycopeptides - metabolism, Renal insufficiency, Renal Insufficiency, Chronic, Biomarkers
Heart Failure, chronic - metabolism, Glycopeptides, Arginine vasopressin - metabolism, Arginine Vasopressin, Heart failure - metabolism, Biomarkers - metabolism, Animals, Humans, Glycopeptides - metabolism, Renal insufficiency, Renal Insufficiency, Chronic, Biomarkers
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 41 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
